Archives of Industrial Hygiene and Occupational Medicine, Volume 2, Issues 1-3American Medical Association, 1950 - Medicine, Industrial |
From inside the book
Results 1-3 of 63
Page 30
... animals contained dust particles , presumably beryllium oxide , in the peribronchial and perivascular tissues TABLE 3. - Beryllium Content ( Micrograms per Gram Wet Weight ) of Tissues in Animals Following Inhalation of Beryllium Oxide ...
... animals contained dust particles , presumably beryllium oxide , in the peribronchial and perivascular tissues TABLE 3. - Beryllium Content ( Micrograms per Gram Wet Weight ) of Tissues in Animals Following Inhalation of Beryllium Oxide ...
Page 337
... animals for 16 hours daily to inhalation of the desired concentrations of the compounds in an airtight , steel gassing chamber of 1,180 L. capacity . Throughout all the chronic exposures the carbon dioxide produced by the animals was ...
... animals for 16 hours daily to inhalation of the desired concentrations of the compounds in an airtight , steel gassing chamber of 1,180 L. capacity . Throughout all the chronic exposures the carbon dioxide produced by the animals was ...
Page 351
... animals were exposed for 18 hours to a concentration of 0.00005 per cent or 0.5 p.p.m. All the animals survived . Three were killed and examined immediately after the exposure . The lungs of all showed large areas of hemorrhage , with ...
... animals were exposed for 18 hours to a concentration of 0.00005 per cent or 0.5 p.p.m. All the animals survived . Three were killed and examined immediately after the exposure . The lungs of all showed large areas of hemorrhage , with ...
Contents
Compensation for Lung Changes Due to the Inhalation of Silica Dust Oscar | 56 |
17 | 89 |
Threshold Limit Values Adopted at the Meeting of the American Con | 98 |
22 other sections not shown
Other editions - View all
Common terms and phrases
1,1-difluoroethane acid aerosol aluminum American Medical Association animals anthracosilicosis arsenic arsine benefits benzene beryllium oxide blood Blue Cross Blue Shield Brožek Cadmium CALIFORN cause cells cent chemical chronic clinical compounds coproporphyrin cor pulmonale cutaneous determined developed dichlorodifluoromethane disability discussion dogs doses dust dyspnea effects emphysema employee evolution excretion experiments exposed exposure fluorescence given hazards hospital increased individual Indust Industrial Health Industrial Hygiene industrial medicine inhaled involved kidney laboratory lead liver lung material medical profession method observed occupational diseases operation particles patient period persons PHILIP DRINKER placebo plant present problems produced public health pulmonary radiation radioactive rats reported respiratory samples sawdust concentrate silicosis slide solution stibine sulfur sulfur dioxide sulfur hexafluoride supervisor symptoms temperature tests tissue toxic treatment tripelennamine tripelennamine hydrochloride uranium urine vapors wet dross workers worry